Children's Brain Tumour Research Centre

  • Print
   
   

International consortium to accelerate safer and more effective treatment for children's brain tumours

 

Brain tumours are the leading cause of cancer-related death in children and young adults. A major challenge to improving this outcome, is developing effective treatments that can cross the protective ‘blood brain barrier’ to directly target tumours in the brain.

Now, a new international consortium has been launched to bring together world-leading experts to take on this challenge, by exploring the use of novel drug delivery systems to physically bypass the blood brain barrier.

The Children’s Brain Tumour Drug Delivery Consortium, led by Professor David Walker at The University of Nottingham, is a two-year initiative funded with a £194,000 grant from the national charity Children with Cancer UK.

Click here for full story.

Posted on Thursday 15th December 2016